Literature DB >> 7926900

Interobserver variation in assessment of gastroduodenal lesions associated with non-steroidal anti-inflammatory drugs.

N Hudson1, S Everitt, C J Hawkey.   

Abstract

Video endoscopic images were used to investigate whether gastroenterologists could agree on the definition of lesions within the stomach seen at endoscopy, with particular reference to those seen in patients taking non-steroidal anti-inflammatory drugs. Seven experienced endoscopists, unaware of the patients' clinical history or drug consumption, recorded their classification for 93 randomised video images of gastric lesions. There was complete agreement in the diagnosis of ulceration for nine images from patients who were not taking non-steroidal anti-inflammatory drugs; eight of nine were classified as deep ulcers, with 86% agreement for this subclassification. By contrast, the overall agreement for lesions in patients taking non-steroidal anti-inflammatory drugs was only 55%. Only nine of 44 ulcers were subclassified as deep, and there was considerable cross classification of non-haemorrhagic erosions and ulcers. In conclusion, ulcers that occur in patients taking non-steroidal anti-inflammatory drugs differ from those in patients who are not taking these drugs in that they are often more superficial and difficult to distinguish from erosions. The prognostic importance of these lesions is, therefore, uncertain.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7926900      PMCID: PMC1375049          DOI: 10.1136/gut.35.8.1030

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  14 in total

Review 1.  Non-steroidal anti-inflammatory drugs and peptic ulcers.

Authors:  C J Hawkey
Journal:  BMJ       Date:  1990-02-03

2.  Prevalence of mucosal lesions in the stomach and duodenum due to chronic use of NSAID in patients with rheumatoid arthritis or osteoarthritis, and interim report on prevention by misoprostol of diclofenac associated lesions.

Authors:  G S Geis; H Stead; C B Wallemark; P A Nicholson
Journal:  J Rheumatol Suppl       Date:  1991-03

Review 3.  Non-steroid anti-inflammatory drug associated ulcer: epidemiology, causation and treatment.

Authors:  M J Langman; P Brooks; C J Hawkey; F Silverstein; N Yeomans
Journal:  J Gastroenterol Hepatol       Date:  1991 Sep-Oct       Impact factor: 4.029

4.  Incidence of gastric lesions in patients with rheumatic disease on chronic aspirin therapy.

Authors:  G R Silvoso; K J Ivey; J H Butt; O O Lockard; S D Holt; C Sisk; W N Baskin; P A Mackercher; J Hewett
Journal:  Ann Intern Med       Date:  1979-10       Impact factor: 25.391

5.  Gastroesophageal endoscopic features in cirrhosis. Observer variability, interassociations, and relationship to hepatic dysfunction.

Authors:  P Calès; B Zabotto; C Meskens; J P Caucanas; J P Vinel; H Desmorat; J Fermanian; J P Pascal
Journal:  Gastroenterology       Date:  1990-01       Impact factor: 22.682

6.  The prevalence of duodenal lesions in patients with rheumatic diseases on chronic aspirin therapy.

Authors:  O O Lockard; K J Ivey; J H Butt; G R Silvoso; C Sisk; S Holt
Journal:  Gastrointest Endosc       Date:  1980-02       Impact factor: 9.427

7.  The effects of ibuprofen, indomethacin, aspirin, naproxen, and placebo on the gastric mucosa of normal volunteers: a gastroscopic and photographic study.

Authors:  F L Lanza; G L Royer; R S Nelson; T T Chen; C E Seckman; M F Rack
Journal:  Dig Dis Sci       Date:  1979-11       Impact factor: 3.199

8.  Gastroduodenal mucosa and dyspeptic symptoms in arthritic patients during chronic nonsteroidal anti-inflammatory drug use.

Authors:  E N Larkai; J L Smith; M D Lidsky; D Y Graham
Journal:  Am J Gastroenterol       Date:  1987-11       Impact factor: 10.864

9.  Effect of anti-inflammatory drug administration in patients with rheumatoid arthritis. An endoscopic assessment.

Authors:  A D Morris; S D Holt; G R Silvoso; J Hewitt; W Tatum; J Grandione; J H Butt; K J Ivey
Journal:  Scand J Gastroenterol Suppl       Date:  1981

10.  How reliable is determination of ulcer size by endoscopy?

Authors:  A Sonnenberg; M Giger; L Kern; C Noll; K Study; K B Weber; A L Blum
Journal:  Br Med J       Date:  1979-11-24
View more
  2 in total

1.  Healing with basic fibroblast growth factor is associated with reduced indomethacin induced relapse in a human model of gastric ulceration.

Authors:  M A Hull; A Knifton; B Filipowicz; J L Brough; G Vautier; C J Hawkey
Journal:  Gut       Date:  1997-02       Impact factor: 23.059

2.  Basic fibroblast growth factor treatment for non-steroidal anti-inflammatory drug associated gastric ulceration.

Authors:  M A Hull; D J Cullen; N Hudson; C J Hawkey
Journal:  Gut       Date:  1995-11       Impact factor: 23.059

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.